ID: ALA4646368

Max Phase: Preclinical

Molecular Formula: C55H61N13O9

Molecular Weight: 1048.17

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(NC(=O)c2ccc(CN3CCN(C(=O)CCCc4cn(CCOCCOCCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)nn4)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1

Standard InChI:  InChI=1S/C55H61N13O9/c1-37-10-15-41(33-46(37)61-55-58-20-18-44(60-55)40-5-4-19-56-34-40)59-51(71)39-13-11-38(12-14-39)35-65-22-24-66(25-23-65)49(70)9-2-6-42-36-67(64-63-42)26-28-76-30-32-77-31-29-75-27-21-57-45-8-3-7-43-50(45)54(74)68(53(43)73)47-16-17-48(69)62-52(47)72/h3-5,7-8,10-15,18-20,33-34,36,47,57H,2,6,9,16-17,21-32,35H2,1H3,(H,59,71)(H,58,60,61)(H,62,69,72)

Standard InChI Key:  VUQOGXGCYSGFPE-UHFFFAOYSA-N

Associated Targets(Human)

Cereblon/BCR/ABL 220 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1048.17Molecular Weight (Monoisotopic): 1047.4715AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Yang Y, Gao H, Sun X, Sun Y, Qiu Y, Weng Q, Rao Y..  (2020)  Global PROTAC Toolbox for Degrading BCR-ABL Overcomes Drug-Resistant Mutants and Adverse Effects.,  63  (15): [PMID:32657579] [10.1021/acs.jmedchem.0c00967]

Source